Cadila Pharma spreads wings to Rwanda

09 Mar 2011 Evaluate

Ahmedabad-based Cadila Pharmaceuticals Ltd is all set to step into Rwandan soil. CSM Global Pharma, a joint venture between Cadila Pharma and US-based Holtzman Group will invest $65 million to set up a pharmaceutical manufacturing facility in Kigali, Rwanda in association with the Rwandan Development Board (RDB). The plant would manufacture solids, tablets and capsules; liquids, gels, ointments, creams and syrups; biologicals, injectables and vaccines and active pharmaceutical ingredients (APIs). It would be fully operational by 2015.


Cadila already has presence in Africa through a 60:40 joint venture with a local partner Almeta Impex. The joint venture firm called Cadila Pharmaceuticals (Ethiopia) PLC is operational since the last three years and is expected to clock a turnover of Rs 20 crore for the year 2010. Rwanda currently depends on imports to meet its requirement for pharmaceutical products. The CSM Global Pharma plant is likely to improve the country's self-sufficiency in terms of drugs production.


Cadila also has a joint venture with NASDAQ listed company Novavax Inc. USA called CPL Biologicals Pvt Ltd. Cadila holds 80 per cent equity in the JV, while the remaining is with Novavax. The JV is working in the area of development and manufacturing of therapeutic and prophylactic vaccines, biological therapeutics and diagnostics in India. The JVC is in the process of developing novel vaccines based on “Virus Like Particles” (VLP) technology.

Zydus Lifesciences Share Price

932.20 -3.00 (-0.32%)
05-Dec-2025 15:22 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1274.45
Cipla 1521.15
Zydus Lifesciences 932.20
Lupin 2098.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×